Old drug, new target: can a fungus fighter slow brain cancer?
NCT ID NCT04825275
Summary
This small, early-stage study aimed to see if a common antifungal drug called posaconazole could get into brain tumors at high enough levels to potentially stop cancer cells from growing. Researchers gave the drug to a few adults with a type of aggressive brain cancer before their surgery. They used special catheters to measure the drug levels directly in the brain and tumor tissue to see if it was worth studying further as a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.